Sign In
Buy RHHBY
$49.06
-0.130 (-0.264%)
At Close: Jun 03, 2026
Market Today: Trump Housing Ban, Apple Card Shift, ISM Jump
05:34pm, Wednesday, 07'th Jan 2026
Guru Stock PicksRon Baron has made the following transactions:Add in CHH by 39.44%Manning and Napier Group, LLC has made the following transactions:Reduce in RMOP
First Look: Nvidia, Ford, Novo Nordisk and Hyundai in Focus
07:39am, Wednesday, 07'th Jan 2026
Stock News WBD sticks with Netflix deal: Warner Bros. Discovery (WBD) again rejected Paramount's (PARA) hostile bid, reaffirming its $72B agreement to sell its
Ventyx (VTYX) Shares Soar 62.5% Overnight, Here's What's Going On With This Trending Stock
10:14pm, Tuesday, 06'th Jan 2026
Ventyx shares jumped in after-hours trading following reports that Eli Lilly is in advanced talks to acquire the biopharma company for over $1 billion.
Market Today: Records, robots, obesity pill, and AI tie-ups
05:35pm, Tuesday, 06'th Jan 2026
Stock News Regulators press X over Grok deepfakes: UK authorities and EU officials demanded action after reports that X's Grok chatbot generated nonâconsensua
Iran will not fall because of the US: David Roche
03:26am, Monday, 05'th Jan 2026
David Roche from Quantum Strategy talks about the protests in Iran, and possibilities for regime change there. He explains why even if the US were to intervene in Iran, it would not fuel a regime chan
What's Going On With Royalty Pharma Stock Wednesday?
10:47am, Wednesday, 31'st Dec 2025
Royalty Pharma has acquired PTC's remaining royalty on Roche's Evrysdi for $240 million upfront and sales-based milestones.
Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones
04:40pm, Monday, 29'th Dec 2025
NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired the final portion of PTC Therapeutics' remaining royalty on Roche's Evrysdi for $240
FDA Approves Genentech's Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
01:00am, Monday, 22'nd Dec 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved CD20xCD
Roche CEO points to higher future drug prices in Switzerland after US deal
04:41pm, Saturday, 20'th Dec 2025
Deals between pharmaceutical companies and Washington to reduce prices for medicines in the United States will likely push up the cost of new drugs in Switzerland, the CEO of Swiss pharma giant Roche
Analysts Set Roche Holding AG (OTCMKTS:RHHBY) Target Price at $57.00
04:26am, Saturday, 20'th Dec 2025
Shares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have been given an average recommendation of "Moderate Buy" by the eight ratings firms that are currently covering the firm, MarketBeat.com
Trump strikes deal with US drugmakers to cut Medicaid medicine costs
03:14pm, Friday, 19'th Dec 2025
Officials pledge ‘massive savings' as companies agree to offer drugs at prices paid in other wealthy countries
Nine of the largest pharma companies ink deals with Trump to lower drug prices
02:34pm, Friday, 19'th Dec 2025
Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation's drug
Genentech Announces Agreement With U.S. Government
02:28pm, Friday, 19'th Dec 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced an agreement with the U.S. government that lowers costs for state Medicaid
Novartis, Roche back US efforts to lower drug costs amid talk of pricing deal
04:30am, Thursday, 18'th Dec 2025
Swiss pharma giants Novartis and Roche on Thursday backed U.S. efforts to lower the cost of drugs and are working with the Trump administration towards that goal following a report they are close to a
Novartis, Roche near US drug price deal, Bloomberg News reports
01:14pm, Wednesday, 17'th Dec 2025
The White House is set to announce drug pricing deals with pharmaceutical heavyweights Novartis AG and Roche Holding AG as soon as Friday, Bloomberg News reported on Wednesday citing people familiar w
